Cases of less-than-expected FVIII activity in previously treated patients during post-marketing surveillance of N8-GP.

Oldenburg, Johannes; Benson, Gary; Chowdary, Pratima; Halimeh, Susan; Matsushita, Tadashi; Nørland, Anne; Wahid, Mohd Nawi; Nemes, Laszlo

Oldenburg, Johannes; Benson, Gary; Chowdary, Pratima; Halimeh, Susan; Matsushita, Tadashi; Nørland, Anne; Wahid, Mohd Nawi; Nemes, Laszlo.

Afiliación

Oldenburg J; Institute for Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany.
Benson G; Department of Haematology, Belfast City Hospital, Belfast, UK.
Chowdary P; Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London, UK.
Halimeh S; Rhine Ruhr Coagulation Centre, Duisburg, Germany.
Matsushita T; Nagoya University Hospital, Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
Nørland A; Novo Nordisk A/S, Søborg, Denmark.
Wahid MN; Novo Nordisk Health Care AG, Zurich, Switzerland.
Nemes L; DepartmentMedical Center of the Hungarian Defence Forces, National Hemophilia Center and Hemostasis, Budapest, Hungary.

Haemophilia ; 29(6): 1475-1482, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37729439

Asunto(s)

Hemofilia A; Hemostáticos; Humanos; Factor VIII/uso terapéutico; Polietilenglicoles/uso terapéutico; Hemofilia A/tratamiento farmacológico; Hemorragia/etiología; Hemorragia/prevención & control; Hemostáticos/uso terapéutico; Semivida; Vigilancia de Productos Comercializados

Palabras clave

FVIII; N8-GP; blood coagulation; haemophilia; post-marketing product surveillance

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hemostáticos / Hemofilia A Tipo de estudio: Guideline / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Haemophilia Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google